Instead of the usual three-ply design, the five-ply surgical mask includes an additional antiviral inner layer which incorporates nano-copper created using a patented process developed at the university.
The copper, which is embedded into the mask material, has ions that are emitted once in contact with a virus and this then creates an interaction with the virus’s genetic material causing it to die and stop reproducing.
Because they are spherical, nanoparticles have a large surface area making the approach more effective at killing the virus. The antiviral inner layer ensures additional protection for both the wearer and those in proximity.
Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).